Comparing Anteris Technologies Global (NASDAQ:AVR) and STERIS (NYSE:STE)

STERIS (NYSE:STE) and Anteris Technologies Global (NASDAQ:AVR) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

Profitability

This table compares STERIS and Anteris Technologies Global’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
STERIS	8.66%	13.91%	8.64%
Anteris Technologies Global	N/A	N/A	N/A

Valuation & Earnings

This table compares STERIS and Anteris Technologies Global”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STERIS	$5.40 billion	4.01	$378.24 million	$4.71	46.78
Anteris Technologies Global	$2.71 million	68.83	N/A	N/A	N/A

STERIS has higher revenue and earnings than Anteris Technologies Global.

Analyst Recommendations

This is a breakdown of current ratings and target prices for STERIS and Anteris Technologies Global, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STERIS	0	1	4	0	2.80
Anteris Technologies Global	0	0	4	0	3.00

STERIS currently has a consensus target price of $258.75, indicating a potential upside of 17.43%. Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 218.53%. Given Anteris Technologies Global’s stronger consensus rating and higher possible upside, analysts plainly believe Anteris Technologies Global is more favorable than STERIS.

Institutional & Insider Ownership

94.7% of STERIS shares are held by institutional investors. 1.1% of STERIS shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

STERIS beats Anteris Technologies Global on 6 of the 9 factors compared between the two stocks.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.